Where do we stand with hepatoblastoma? A review.

@article{Schnater2003WhereDW,
  title={Where do we stand with hepatoblastoma? A review.},
  author={Johannes Marco Schnater and S Eleonore K{\"o}hler and Wouter H. Lamers and Dietrich von Schweinitz and Dani{\"e}l C Aronson},
  journal={Cancer},
  year={2003},
  volume={98 4},
  pages={668-78}
}
Hepatoblastoma (HB) is the most common pediatric liver malignancy, comprising approximately 1% of all pediatric cancers. The disparate clinical staging systems and histologic classifications that were developed during the last decades, nevertheless, reflect the remaining difficulties and uncertainties in characterizing HB. Furthermore, the combination of surgery and (neo)adjuvant chemotherapy has improved patient outcomes dramatically. A poor prognosis is associated with large tumor size… CONTINUE READING